Study of MHB088C for Patients With Advanced Solid Malignant Tumors

NCT07102004 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG: MHB088C for Injection

Sponsor

Qilu Pharmaceutical Co., Ltd.